Skip to main content
OpenTrials

Clinical trial condition

Primary Mediastinal Large B-Cell Lymphoma Recurrent

Explore clinical trials studying Primary Mediastinal Large B-Cell Lymphoma Recurrent. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Primary Mediastinal Large B-Cell Lymphoma Recurrent trial results

Recruiting

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

NCT05934448

Conditions
Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma Recurrent, +3 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)

NCT06504394

Conditions
Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Parkinson Disease 4, Autosomal Dominant Lewy Body, +2 more
Locations
  • University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) Iowa City, Iowa, United States
  • University of Iowa - Waukee ( Site 0111) Waukee, Iowa, United States
  • Comprehensive Cancer Centers of Nevada ( Site 0114) Las Vegas, Nevada, United States
  • Clinical Research Alliance ( Site 0101) Westbury, New York, United States
View all 29 locations
View Trial Details

Related conditions